Stocks
Cellectar Biosciences, Inc.CLRB
NASDAQHealthcareBiotechnology$1.22
Price as of · delayed, not real-time
Cellectar Biosciences is a clinical-stage biopharmaceutical company developing phospholipid drug conjugates (PDCs) for the treatment of cancers, with a lead candidate, iopofosine I 131, targeting hematologic malignancies such as Waldenström macroglobulinemia and multiple myeloma. Investors track the company for its upcoming regulatory milestones and the potential of its PDC platform to improve the therapeutic index of cytotoxic agents.
52W Range: $1.12-$4.70
Congressional Interest in Cellectar Biosciences, Inc. (CLRB)
No congressional trades have been disclosed for Cellectar Biosciences, Inc. (CLRB) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading CLRB?
No congressional trades found for this stock.